同步性多灶性骨肉瘤中68Ga-DOTATATE弥漫性摄取而18F-FDG骨显像不显著一例
Diffuse Increased 68Ga-DOTATATE But Unimpressive 18F-FDG Osseous Activity in a Patient With Rapid-Progressing Synchronous Multifocal Osteosarcoma.
PubMed 文献 · Clin Nucl Med · 2020-01-01
本文报道一名18岁年轻男性,影像学见广泛成骨性及轻度溶骨性改变,骨病灶68Ga-DOTATATE摄取弥漫性增高,而18F-FDG PET/CT未见明显异常。结合病理、临床及影像特征,最终诊断为同步性多灶性骨肉瘤。提示骨肉瘤通常18F-FDG高摄取,但本例表现不典型。
要点
- 骨肉瘤通常18F-FDG高摄取,但本例18F-FDG PET/CT骨显像不显著。
- 本例骨病灶68Ga-DOTATATE摄取弥漫性增高。
- 最终诊断为同步性多灶性骨肉瘤。
核心结论
- 同步性多灶性骨肉瘤可表现为骨病灶68Ga-DOTATATE摄取弥漫性增高而18F-FDG PET/CT骨显像不显著。
研究设计与样本
- 个案报道,报道一名18岁年轻男性患者的临床、病理及影像特征。
主要发现
- 患者影像学见广泛成骨性及轻度溶骨性改变。
- 骨病灶68Ga-DOTATATE摄取弥漫性增高。
- 18F-FDG PET/CT骨显像未见明显异常。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Osteosarcoma is usually F-FDG-avid. Here we report a case of an 18-year-old young man with widespread osteoblastic and slight osteolytic changes, which had diffusely increased Ga-DOTATATE uptake in the osseous lesions, whereas the F-FDG PET/CT was unrevealing. The final diagnosis is synchronous multifocal osteosarcoma based on the pathological, clinical, and imaging features.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Qin C, Shao F, Lan X, et al. Diffuse Increased 68Ga-DOTATATE But Unimpressive 18F-FDG Osseous Activity in a Patient With Rapid-Progressing Synchronous Multifocal Osteosarcoma. Clin Nucl Med. 2020. PMID: 32796243. doi:10.1097/RLU.0000000000003228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。